Yep, quite astounding, really. Management gave everyone the impression that FDA approval was a sure thing. The chairman even spun a story at the agm denying Morgan Stanley were shorting the stock, but rather using the stock as collateral over other stocks.
CYC Price at posting:
$1.74 Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)